Advertisement
UK markets close in 4 hours 45 minutes
  • FTSE 100

    7,952.37
    +20.39 (+0.26%)
     
  • FTSE 250

    19,862.88
    +52.22 (+0.26%)
     
  • AIM

    743.40
    +1.29 (+0.17%)
     
  • GBP/EUR

    1.1695
    +0.0026 (+0.23%)
     
  • GBP/USD

    1.2618
    -0.0020 (-0.16%)
     
  • Bitcoin GBP

    55,882.36
    +225.54 (+0.41%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CRUDE OIL

    82.57
    +1.22 (+1.50%)
     
  • GOLD FUTURES

    2,231.30
    +18.60 (+0.84%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,489.88
    +12.79 (+0.07%)
     
  • CAC 40

    8,230.29
    +25.48 (+0.31%)
     

The Vertex Pharmaceuticals Inc share price at 283.75: three reasons it could go higher

Often the real stock market winners are not shares that look obviously cheap compared to book value or earnings – instead they are the slightly more expensive, high-quality operators with improving outlooks.

Vertex Pharmaceuticals Inc (NSQ:VRTX) might be one of them. Here's why.

GET MORE DATA-DRIVEN INSIGHTS INTO NSQ:VRTX »

Capital allocation - it's harder than it looks

Top analysts and investors such as Warren Buffett and Michael Mauboussin say capital allocation - the deployment of company time, money, ideas, and people - is the key to building moat-like quality and profitability characteristics.

ADVERTISEMENT

Unfortunately, CEOs are not generally promoted based on their ability to allocate capital, even though this is what they then go on to spend their time doing. Buffett sums it up nicely in his 1987 letter to shareholders:

“Most bosses rise to the top because they have excelled in an area such as marketing, production, engineering, administration or, sometimes, institutional politics.

Once they become CEOs, they face new responsibilities. They now must make capital allocation decisions, a critical job that they may have never tackled and that is not easily mastered. To stretch the point, it’s as if the final step for a highly-talented musician was not to perform at Carnegie Hall but instead, to be named Chairman of the Federal Reserve.”

So if you’re only looking at sales and earnings growth, there is a vital question not being considered: how is this growth being funded?

Screening for upwardly mobile, high-quality companies

That’s where ratios like return on equity (ROE) come in. ROE measures how efficiently a company uses Shareholders’ Equity to generate profits. It is calculated by dividing net income by book value of equity.

It’s no coincidence that Buffett is a fan of the measure - companies with high ROEs tend to exhibit the high-quality, moat-like business traits that he is so fond of gaining exposure to.

To find high ROE stocks whose fantastic business models are being rewarded by the market, you can create a stock screen that selects only stocks with both positive one-year relative strength and upgraded current year broker forecasts. The former ensures these shares have been outperforming the market and the latter suggests outperformance can continue.

One of the stocks that currently qualifies for this simple screen is Vertex Pharmaceuticals Inc. The group has:

  • A trailing twelve month return on equity of 27.0%

  • An average current year EPS forecast upgrade of 14.8% from brokers, and

  • A one-year relative strength of 64.5%

Stocks exhibiting these traits are typically a solid mix of quality and momentum. Vertex Pharmaceuticals Inc has a Quality Rank of 97 and a Momentum Rank of 99.

Studies indicate that combining factors such as Value, Quality and Momentum is a more effective way of outperforming the market over longer time frames. That's why we have constructed our StockReports to give an instant impression of how well exposed Vertex Pharmaceuticals Inc (NSQ:VRTX) is to these three factors. We go into greater detail on factor investing in this video.

Stockopedia helps you to identify return-enhancing factors such as Quality, Value and Momentum by analysing thousands of data points every day. To find out more about you find investment opportunities and analyse your portfolios then take one of our two-week free trials and have a look around.